Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019

SELL
$105.9 - $118.64 $15,885 - $17,796
-150 Closed
0 $0
Q1 2018

Sep 25, 2018

SELL
$74.21 - $87.6 $7,420 - $8,760
-100 Reduced 40.0%
150 $12,000
Q4 2017

Sep 25, 2018

BUY
$81.94 - $87.89 $20,485 - $21,972
250
250 $21,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Portfolio Strategies, Inc. Portfolio

Follow Portfolio Strategies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portfolio Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portfolio Strategies, Inc. with notifications on news.